Ignite Creation Date:
2025-12-24 @ 12:10 PM
Ignite Modification Date:
2025-12-27 @ 9:43 PM
Study NCT ID:
NCT02729961
Status:
WITHDRAWN
Last Update Posted:
2019-10-10
First Post:
2016-03-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma
Sponsor:
University of Washington
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-03
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2016-03-29
First Submit QC Date:
None
Study First Post Date:
2016-04-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-08
Last Update Post Date:
2019-10-10
Last Update Post Date Type:
ACTUAL